Antifungal amphiphilic aminoglycoside K20: Bioactivities and mechanism of action

Frontiers in Microbiology

Volumn 5, Issue DEC, 2014, Pages

  Shrestha, Sanjib K ^a   Chang, Cheng Wei T ^a   Meissner, Nicole ^b   Oblad, John ^a   Shrestha, Jaya P ^a   Sorensen, Kevin N ^c   Grilley, Michelle M ^a   Takemoto, Jon Y ^a  

^a UTAH STATE UNIVERSITY   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c Snow College   (United States)

Author keywords

Amphiphilic aminoglycoside; Antifungal; Cryptococcus neoformans; K20; Kanamycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CALCEIN; FLUCONAZOLE; ITRACONAZOLE; K20; KANAMYCIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY; DISK DIFFUSION; DRUG MECHANISM; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUSARIUM GRAMINEARUM; GROWTH INHIBITION; HEMOLYSIS; MINIMAL FUNGICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PHARMACOLOGICAL PARAMETERS; SHEEP ERYTHROCYTE; STAPHYLOCOCCUS AUREUS;

ANIMALIA; CRYPTOCOCCUS NEOFORMANS VAR. GRUBII H99; FILOBASIDIELLA NEOFORMANS; FUNGI; GIBBERELLA ZEAE; MAMMALIA; MURINAE;

EID: 84920697290     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00671     Document Type: Article

References (40)

1. 2, a plant defensin from raphanus sativus, involves the induction of reactive oxygen species in Candida albicans. J. Mol. Microbiol. Biotechnol. 13, 243-247. doi: 10.1159/000104753
2. Begg, E. J., and Barclay, M. L. (1995). Aminoglycosides 50 years on. Brit. J. Clin. Pharmacol. 39, 597-603.
3. Chang, C. W. T., Fosso, M. Y., Kawasaki, Y., Shrestha, S., Bensaci, M. F., Wang, J., et al. (2010). Antibacterial to antifungal conversion of neamine aminoglycosides through alkyl modification. Strategy for reviving old drugs into agrofungicides. J. Antibiot. 63, 667-672. doi: 10.1038/ja.2010.110
4. Chang, C. W. T., and Takemoto, J. Y. (2012). Aminoglycosides: Synthesis and Use as Antifungals. Appl. No. 13/316,720, US 2012/0316125 A1. Alexandria, VA: U.S. Patent and Trademark Office.
5. Chang, C. W. T., and Takemoto, J. Y. (2014). Antifungal amphiphilic aminoglycosides. Med. Chem. Comm. 5, 1048-1057. doi: 10.1039/C4MD00078A
6. Dartois, V., Sanchez-Quesada, J., Cabezas, E., Chi, E., Dubbelde, C., Dunn, C., et al. (2005). Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob. Agents Chemother. 49, 3302-3310. doi: 10.1128/AAC.49.8.3302-3310.2005
7. Ferket, K. K., Levery, S. B., Park, C., Cammue, B. P., and Thevissen, K. (2003). Isolation and characterization of Neurospora crassa mutants resistant to antifungal plant defensins. Fungal Genet. Biol. 40, 176-185. doi: 10.1016/S1087-1845(03)00085-9
8. Fisher, M. C., Henk, D. A., Briggs, C. J., Brownstein, J. S., Madoff, L. C., McCraw, S. L., et al. (2012). Emerging fungal threats to animal, plant and ecosystem health. Nature 484, 186-194. doi: 10.1038/nature10947
9. Fukushima, K., Liu, S., Wu, H., Engler, A. C., Coady, D. J., Maune, H., et al. (2013). Supramolecular high-aspect ratio assemblies with strong antifungal activity. Nature Comm. 4, 2861. doi: 10.1038/ncomms3861
10. Grilley, M. M., Stock, S. D., Dickson, R. C., Lester, R. L., and Takemoto, J. Y. (1998). Syringomycin action gene SYR2 is essential for sphingolipid 4- hydroxylation in Saccharomyces cerevisiae. J. Biol. Chem. 273, 11062-11068. doi: 10.1074/jbc.273.18.11062
11. Im, Y. J., Idkowiak-Baldys, J., Thevissen, K., Cammue, B. P. A., and Takemoto, J. Y. (2003). IPT1-independent sphingolipid biosynthesis and yeast inhibition by syringomycin E and plant defensin DmAMP1. FEMS Microbiol. Lett. 223, 199-203. doi: 10.1016/S0378-1097(03)00375-6
12. Jarvis, J. N., and Harrison, T. S. (2008). Pulmonary cryptococcosis. Semin. Respir. Crit. Care Med. 29, 141-150. doi: 10.1055/s-2008-1063853
13. Klepser, M. E., Malonel, D., Lewis, R. E., Ernst, E. J., and Pfaller, M. A. (2000). Evaluation of voriconazole pharmacodynamics using time-kill methodology. Antimicrob. Agents Chemother. 40, 1917-1920. doi: 10.1128/AAC.44.7.1917-1920.2000
14. Lay, F. T., Brugliera, F., and Anderson, M. A. (2003). Isolation and properties of floral defensins from ornamental tobacco and petunia. Plant Physiol. 131, 1283-1293. doi: 10.1104/pp.102.016626
15. Lee, H. B., Kim, Y., Kim, J. C., Choi, G. J., Park, S. H., Kim, C. J., et al. (2005). Activity of some aminoglycoside antibiotics against true fungi, Phytophthora and Pythium species. J. Appl. Microbiol. 99, 836-843. doi: 10.1111/j.1365-2672.2005.02684.x
16. Lee, J., Park, C., Park, S. C., Woo, E. R., Park, Y., Hahm, K. S., et al. (2009). Cell selectivity membrane phospholipids relationship of the antimicrobial effects shown by pleurocidinenantiomeric peptides. J. Pept. Sci. 15, 601-606. doi: 10.1002/psc.1157
17. Lester, R. L., and Dickson, R. C. (1993). Sphingolipids with inositolphosphate-containing head groups. Adv. Lipid Res. 26, 253-274.
18. Makovitzki, A., Avrahami, D., and Shai, Y. (2006). Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. U.S.A. 103, 15997-16002. doi: 10.1073/pnas.0606129103
19. Makovitzki, A., Baram, J., and Shai, Y. (2008). Antimicrobial lipopolypeptides composed of palmitoyl Di- and tricationic peptides: in vitro and in vivo activities, self-assembly to nanostructures, and a plausible mode of action. Biochem. 47, 10630-10636. doi: 10.1021/bi8011675
20. Mangoni, M. L., Papo, N., Barra, D., Simmaco, M., Bozzi, A., Di Giulio, A., et al. (2004). Effect of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem. J. 380, 859-865. doi: 10.1042/BJ20031975
21. NCCLS. (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-Third Edition: Approved Standard M27-A3. Wayne, PA: National Committee for Clinical Laboratory Standards.
22. NCCLS. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Third Edition: Approved Standard M7-A3. Villanova, PA: National Committee for Clinical Laboratory Standards.
23. NCCLS. (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi-Second Edition: Approved Standard M38-A2. Wayne, PA: National Committee for Clinical Laboratory Standards.
24. Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., and Chiller, T. M. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids 23, 525-530. doi: 10.1097/QAD.0b013e328322ffac
25. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
26. Searles, S., Gauss, K., Wilkison, M., Hoyt, T. R., Dobrinen, E., and Meissner, N. (2013). Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to pneumocystis lung infection. J. Immunol. 191, 3884-3895. doi: 10.4049/jimmunol.1301344
27. Segre, A., Bachmann, R. C., Ballio, A., Bossa, F., Grgurina, I., Iacobellis, N. S., et al. (1989). The structure of syringomycin-A1, Syringomycin-E and Syringomycin-G. FEBS Lett. 255, 27-31. doi: 10.1016/0014-5793(89)81054-3
28. Shirley, R. M., and Baddley, J. W. (2009). Cryptococcal lung disease. Curr. Opin. Pulm. Med. 15, 254-260. doi: 10.1097/MCP.0b013e328329268d
29. Shrestha, S., Grilley, M., Fosso, M. Y., Chang, C. W., and Takemoto, J. Y. (2013). Membrane lipid-modulated mechanism of action and non-cytotoxicity of novel fungicide aminoglycoside FG08. PLoS ONE 8:e73843. doi: 10.1371/journal.pone.0073843
30. Stock, S. D., Hama, H., Radding, J. A., Young, D. A., and Takemoto, J. Y. (2000). Syringomycin E inhibition of Saccharomyces cerevisiae: requirement for biosynthesis of sphingolipids with very-long-chain fatty acids and mannose- and phosphoinositol-containing head groups. Antimicrob. Agents Chemother. 44, 1174-1180. doi: 10.1128/AAC.44.5.1174-1180.2000
31. Strange, R. N., and Scott, P. R. (2005). Plant disease: a threat to global food security. Ann. Rev. Phytopathol. 43, 83-116. doi: 10.1146/annurev.phyto.43.113004.133839
32. Sugimoto, Y., Sakoh, H., and Yamada, K. (2004). IPC synthase as a useful target for antifungal drugs. Curr. Drug Targets Infect. Disorders 4, 311-322. doi: 10.2174/1568005043340597
33. Thevissen, K., Cammue, B. P., Lemaire, K., Winderickx, J., Dickson, R. C., Lester, R. L., et al. (2000). A gene encoding a sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia merckii). Proc. Natl. Acad. Sci. U.S.A. 97, 9531-9536. doi: 10.1073/pnas.160077797
34. Thevissen, K., De Mello Tavares, P., Xu, D., Blankenship, J., Vandenbosch, D., Idkowiak-Baldys, J., et al. (2012). The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans. Mol. Microbiol. 84, 166-180. doi: 10.1111/j.1365-2958.2012.08017.x
35. Thevissen, K., Francois, I. E., Takemoto, J. Y., Ferket, K. K., Meertt, E. M., and Cammue, B. P. (2003). DmAMP1, an antifungal plant defensin from dahlia (Dahlia merckii), interacts with sphingolipids from Saccharomyces cerevisiae. FEMS Microbiol. Lett. 226, 169-173. doi: 10.1016/S0378-1097(03)00590-1
36. Umezawa, H., Ueda, M., Maeda, K., Yagishita, K., Kondo, S., Okami, Y., et al. (1957). Production and isolation of a new antibiotic: kanamycin. J. Antibiot. 10, 181-188.
37. Vakulenko, S. B., and Mobashery, S. (2003). Versatility of aminoglycosides and prospects for their future. Clin. Microbiol. Rev. 16, 430-450. doi: 10.1128/CMR.16.3.430-450.2003
38. Vallon-Eberhard, A., Makovitzki, A., Beauvais, A., Latge, J. P., Jung, S., and Shai, Y. (2008). Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys. Antimicrob. Agents Chemother. 52, 3118-3126. doi: 10.1128/AAC.00526-08
39. Wilhelm, J. M., Pettit, S. E., and Jessop, J. J. (1978). Aminoglycoside antibiotics and eukaryotic protein synthesis: structure-function relationships in the stimulation of misreading with a wheat embryo system. Biochemistry 17, 1143-1149. doi: 10.1021/bi00600a001
40. Zhang, L. J., Rozek, A., and Hancock, R. W. W. (2001). Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276, 35714-35722. doi: 10.1074/jbc.M104925200